Medical News

RSS

Novel pen measures stress levels

In the future, more and more products will be able to interpret what users are feeling and use that information in a smart way. To illustrate the power of this theory, researcher Miguel Bruns Alonso has developed a pen which can measure the stress levels of the person using it, and can actually help to reduce that stress. In experiments, the heart rate of people who used the anti-stress pen fell by an average of five percent. On Wednesday, 23 December, Miguel Bruns Alonso will receive his PhD degree from TU Delft based on his research into this subject.

21 Dec 2010

Country must make wise choices in preventing infections, says study on future of AIDS in Cambodia

Despite Cambodia's remarkable history in driving down HIV infections, a report released today on the future of AIDS in the country argues that future success is not guaranteed and the government needs to focus increasingly on wise prevention tactics and assume more of the financing of its AIDS program.

21 Dec 2010

Dentists recognized for excellence in ethics, leadership and professionalism

Two local dentists were recently recognized for excellence in ethics, leadership and professionalism when they were invited to become Fellows of the American College of Dentists.

21 Dec 2010

ARYx common stock listing to be transferred to NASDAQ Capital Market

ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.

21 Dec 2010

Rodobo fourth quarter revenue increases 172.6% to $25.3 million

Rodobo International, Inc., a fast growing dairy company in China, reported financial results for the fourth quarter and full year ended September 30, 2010.

21 Dec 2010

Study provides evidence on prevalence of two separate mosquito species which carry malaria parasite

In notable back-to-back papers appearing in the prestigioous journal Science in October, teams of researchers, one led by Nora Besansky, a professor of biological sciences and a member of the Eck Institute for Global Health at the University of Notre Dame, provided evidence that Anopheles gambiae, which is one of the major mosquito carriers of the malaria parasite in Sub-Saharan Africa, is evolving into two separate species with different traits.

21 Dec 2010

B-Bridge International unveils first brainwave athletic trainer

B-Bridge International proudly unveils the first brainwave athletic trainer. Powered by NeuroSky, the leader in mass-market Brain-Computer Interface technology, the BrainAthlete system is the first sports training unit available for general consumers to track an athlete's level of concentration, helping them find their "zone." Engineered into a standard golf visor, three non-invasive contact points in the headband monitor the EEG electrical activity from the brain to determine the athlete's mental states.

21 Dec 2010

LUMEDX announces subscription of 50 hospitals to cardiovascular SaaS solution

LUMEDX Corporation, a leading provider of vendor-neutral, integrated medical imaging and information systems, announced today that 50 hospitals now subscribe to its cardiovascular software-as-a-service (SaaS) solution. LUMEDX's SaaS delivery model allows clients to access and utilize software remotely via the web — resulting in faster implementations and lower licensing, maintenance and personnel costs. The service also includes built-in disaster recovery and high-intensity security systems.

21 Dec 2010

Simple ways to limit damage due to holiday drinks loaded with calories

But Loyola University Health System registered dietitian Brooke Schantz says there are simple ways to limit the damage. Here is her advice for how to enjoy five popular holiday drinks:

21 Dec 2010

Majority of Massachusetts physician groups use statewide results to improve patient experiences

Most Massachusetts physician groups are using results from a statewide patient survey to help improve patient experiences, but a significant number are not making use of the information or are making relatively limited efforts, according to a new RAND Corporation study.

21 Dec 2010

Aetna's ACO model improves health care quality, lowers cost of care

Three years ago Aetna began working with doctor groups, specialists and health care facilities to create a more personalized, connected and accountable way to provide health care. Today, Aetna's early accountable care organization model is improving health care quality and lowering the cost of care.

21 Dec 2010

Cambridge Heart completes private placement

Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.

21 Dec 2010

AmeriCares, Baxter team up to deliver IV solutions to prevent cholera outbreak in Haiti

AmeriCares and Baxter International Inc. have teamed to deliver additional lifesaving intravenous solutions to Haiti as part of their ongoing effort to stem the cholera outbreak. AmeriCares has been working around the clock to distribute IV solutions, oral rehydration salts, antibiotics, hand sanitizers and other critical aid since the outbreak was reported in October.

From Baxter International Inc. 21 Dec 2010

New study finds 80% of transfer cases in Illinois take longer than two hours

Illinois law states that when hospitals need to transfer trauma patients to centers with higher levels of trauma care, such transfers should be made within two hours.

21 Dec 2010

Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins

Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.

21 Dec 2010

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Women suffering from uterine fibroids, a debilitating condition that affects more than seven million women in the U.S., may soon have reason for hope. Halt Medical, a biomedical company based in the San Francisco Bay Area, is developing a minimally invasive procedure for treating the condition. The company recently presented their findings from studies in Latin America at the NIH Global Fibroid Congress.

21 Dec 2010

NAMI publishes updated family guide for treating adolescents living with depression

The National Alliance on Mental Illness has published an updated and expanded edition of What Families Need to Know about Adolescent Depression, a guide for families who want to know about accurate diagnosis and effective treatment options for teenagers experiencing depression.

21 Dec 2010

Invitations open for fourth annual Young Investigator Grant for Probiotics Research

Today, the Global Probiotics Council (GPC), a committee formed by Danone and YAKULT HONSHA CO., LTD., announced the launch of the fourth annual Young Investigator Grant for Probiotics Research (YIGPRO). This grant provides two awards, each in the amount of $50,000, to rising young stars. This year's grant focus is on the role of probiotics and gastrointestinal microbiota in health and wellness. Applications will be accepted until February 15, 2011.

21 Dec 2010

Genzyme provides information on peak sale of alemtuzumab for multiple sclerosis

Genzyme Corporation today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.

21 Dec 2010

Researchers present definitive explanation of how fibrotic cells destroy human liver

In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.

21 Dec 2010

Medical News

Novel pen measures stress levels

Country must make wise choices in preventing infections, says study on future of AIDS in Cambodia

Dentists recognized for excellence in ethics, leadership and professionalism

ARYx common stock listing to be transferred to NASDAQ Capital Market

Rodobo fourth quarter revenue increases 172.6% to $25.3 million

Study provides evidence on prevalence of two separate mosquito species which carry malaria parasite

B-Bridge International unveils first brainwave athletic trainer

LUMEDX announces subscription of 50 hospitals to cardiovascular SaaS solution

Simple ways to limit damage due to holiday drinks loaded with calories

Majority of Massachusetts physician groups use statewide results to improve patient experiences

Aetna's ACO model improves health care quality, lowers cost of care

Cambridge Heart completes private placement

AmeriCares, Baxter team up to deliver IV solutions to prevent cholera outbreak in Haiti

New study finds 80% of transfer cases in Illinois take longer than two hours

Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

NAMI publishes updated family guide for treating adolescents living with depression

Invitations open for fourth annual Young Investigator Grant for Probiotics Research

Genzyme provides information on peak sale of alemtuzumab for multiple sclerosis

Researchers present definitive explanation of how fibrotic cells destroy human liver

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News